QIXBELZA

EUIPO EUIPO 2017 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark QIXBELZA was filed as Word mark on 10/02/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/12/2018. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 017285784
Application date October 2, 2017
Publication date January 4, 2018
Entry date April 12, 2018
Expiration date October 2, 2027

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations, for the treatment, diagnosis and/or prevention of gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, pharmaceutical preparations, for the treatment, diagnosis and/or prevention of neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations

Trademark history

Date Document number Area Entry
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11017285784